Related Experiment Video
Updated: Jun 10, 2026

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Published on: June 14, 2024
Neutrophil paralysis in sepsis
José C Alves-Filho1, Fernando Spiller, Fernando Q Cunha
1Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. jcafilho@usp.br
Sepsis causes widespread inflammation and organ dysfunction. This review details the molecular mechanisms behind neutrophil paralysis, a key sepsis feature hindering immune cell movement to infection sites, impacting disease severity.
Area of Science:
- Immunology
- Pathophysiology
- Molecular Biology
Background:
- Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
- Neutrophil paralysis, impaired neutrophil migration to infection sites, is a critical hallmark of sepsis.
- The molecular mechanisms underlying neutrophil paralysis are not fully understood but are crucial for disease severity.
Purpose of the Study:
- To review recent advancements in understanding the molecular mechanisms of neutrophil paralysis during sepsis.
- To highlight key molecular players and pathways involved in impaired neutrophil function in sepsis.
Main Methods:
- Literature review of recent studies on neutrophil function in sepsis.
- Analysis of molecular and cellular mechanisms contributing to neutrophil paralysis.
Main Results:
- Sepsis significantly impairs neutrophil migration and function.
- Specific molecular pathways, including signaling cascades and receptor interactions, are implicated in neutrophil paralysis.
- Understanding these mechanisms is key to developing targeted therapies.
Conclusions:
- Neutrophil paralysis is a central mechanism in sepsis pathogenesis.
- Recent molecular insights offer potential therapeutic targets for sepsis treatment.
- Further research into neutrophil paralysis mechanisms is warranted to improve patient outcomes.
Related Concept Videos
Botulism
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Tetanus
Bacterial Meningitis II: Pathophysiology
Pneumonia II: Pathophysiology
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

